| Product Code: ETC7659791 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Postmenopausal Vaginal Atrophy Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Postmenopausal Vaginal Atrophy Treatment Market - Industry Life Cycle |
3.4 Israel Postmenopausal Vaginal Atrophy Treatment Market - Porter's Five Forces |
3.5 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.7 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Postmenopausal Vaginal Atrophy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about postmenopausal vaginal atrophy (PVA) among women |
4.2.2 Growing demand for non-hormonal treatment options |
4.2.3 Technological advancements leading to more effective and safer treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of FDA-approved treatments for PVA in Israel |
4.3.2 High cost associated with some PVA treatment options |
4.3.3 Social stigma or taboo associated with discussing PVA symptoms, leading to underreporting and undertreatment |
5 Israel Postmenopausal Vaginal Atrophy Treatment Market Trends |
6 Israel Postmenopausal Vaginal Atrophy Treatment Market, By Types |
6.1 Israel Postmenopausal Vaginal Atrophy Treatment Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Estrogen based drugs, 2021- 2031F |
6.1.4 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Non-estrogen based drugs, 2021- 2031F |
6.1.5 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Postmenopausal Vaginal Atrophy Treatment Market, By Drug Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Vaginal gel, 2021- 2031F |
6.2.3 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.4 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2.5 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Postmenopausal Vaginal Atrophy Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Intravaginal, 2021- 2031F |
6.3.4 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Postmenopausal Vaginal Atrophy Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Postmenopausal Vaginal Atrophy Treatment Market Import-Export Trade Statistics |
7.1 Israel Postmenopausal Vaginal Atrophy Treatment Market Export to Major Countries |
7.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Imports from Major Countries |
8 Israel Postmenopausal Vaginal Atrophy Treatment Market Key Performance Indicators |
8.1 Patient satisfaction rates with PVA treatment options |
8.2 Number of healthcare providers trained in diagnosing and treating PVA |
8.3 Percentage increase in women seeking medical help for PVA symptoms |
8.4 Adoption rate of innovative non-hormonal treatment options for PVA |
8.5 Number of clinical trials and research studies focused on PVA treatment options |
9 Israel Postmenopausal Vaginal Atrophy Treatment Market - Opportunity Assessment |
9.1 Israel Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.3 Israel Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Postmenopausal Vaginal Atrophy Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Postmenopausal Vaginal Atrophy Treatment Market - Competitive Landscape |
10.1 Israel Postmenopausal Vaginal Atrophy Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Postmenopausal Vaginal Atrophy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here